EP2872161

DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    24.6.2013
  • :
    16.12.2020
  • :
    13809749.8
  • :
    23.6.2033
  • :
    DIANHYDROGALACTITOL FOR USE IN TREATING TYROSINE-KINASE-INHIBITOR-RESISTANT MALIGNANCIES IN PATIENTS WITH GENETIC POLYMORPHISMS OR AHI1 DYSREGULATIONS OR MUTATIONS

24.6.2013
16.12.2020
  • :
    Del Mar Pharmaceuticals
  • :
    Suite 115-887 Great Northern Way, Vancouver, CA
  • :
    BROWN, Dennis M.
  • :
    Menlo Park, California 94025, US
  • :
    BACHA, Jeffrey A.
  • :
    Vancouver, British Columbia V5T 4T5, CA
  • :
    GARNER, William J.
  • :
    San Francisco, California 94109, US
  • :
    201261664279 P
  • :
    26.6.2012
  • :
    US
  • :
    201361824672 P
  • :
    17.5.2013
  • :
    US
  • :
    US2013047320
  • :
    24.6.2013
  • :
    A61K 31/047, A61K 31/075, A61K 31/336, A61K 45/06, A61K 38/12, A61P 35/00, A61P 35/02